Leadership & Management
Rising trade-offs and trust fractures: Novartis President decodes shifting rules of leadership

As pressure builds across policy, innovation and public expectation, Ali Rossiter, Country President, Novartis ANZ, joins the Health Industry Hub senior leadership podcast series to unpack what leadership demands when certainty itself has become unstable.
Drawing on more than two decades of global leadership experience across diagnostics, ASX-listed healthcare and now multinational pharmaceuticals, Rossiter reflects on the forces reshaping leadership far beyond the walls of any one organisation. Framed by the University of Sydney leadership researchers, the discussion explores a ‘decade of disorientation defined by overlapping disruptions and messy shifts that leave leaders navigating constant ambiguity.
As debates intensify around Health Technology Assessment (HTA) reform and Most Favoured Nation (MFN) pricing policy, Rossiter examines the growing perception that corporations are extracting more value than they create, and how organisations like Novartis are being challenged to respond in environments where government, industry, clinicians and patients rarely move in perfect alignment.
The conversation also turns inward, examining the changing fabric of work itself. As employee expectations fragment across generations, values and definitions of purpose, Rossiter reflects on what organisational cohesion looks like when leaders can no longer assume a shared understanding of work, workplaces and leadership. In sharing advice for the next generation of senior leaders, Rossiter speaks to the challenge of leading through ambiguity without becoming consumed by it.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals
New funding to bring global CAR-T trials to young cancer patients
The government is delivering the first investment under the $300 million MRFF Australian Cancer Research Program (ACRP), to bring international […]
MoreNews - Pharmaceuticals
Rising gynae cancers meets a system forcing patients to pay the price
Sector leaders, government and women with lived experience unite in Canberra today to accelerate evidence-based action, as gynaecological cancer diagnoses […]
MoreNews - MedTech & Diagnostics
Analysis confirms private health insurance cuts target vulnerable pensioners
New analysis by the Parliamentary Budget Office (PBO) shows that half of the $3 billion dollars the Albanese Government expects […]
MoreNews - MedTech & Diagnostics
Chalmers retreats as startup tax backlash forces further changes
The Albanese Government has been forced to retreat from several of the most contentious elements of its proposed startup tax […]
More